Crossmark

A metabolomics-based approach for non-invasive screening of fetal central nervous system anomalies

Crossref DOI link: https://doi.org/10.1007/s11306-018-1370-8

Published Online: 2018-05-25

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Troisi, Jacopo https://orcid.org/0000-0003-2962-7379
Landolfi, Annamaria

Sarno, Laura

Richards, Sean

Symes, Steven

Adair, David

Ciccone, Carla

Scala, Giovanni

Martinelli, Pasquale

Guida, Maurizio
Funding

Funding for this research was provided by:

FARBS 2016
License Information

Text and Data Mining valid from 2018-05-25
More Information

Article History

Received: 12 December 2017

Accepted: 14 May 2018

First Online: 25 May 2018

Compliance with ethical standards

:

: J. Troisi, G. Scala, and M. Guida have an Italian patent for the diagnostic test described in the manuscript (Patent no. 0001423755/2016) and have applied for a PCT extension. All the other authors have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethics committee (IRB n.4/2013) and a written consent form was signed by each participant.